240 related articles for article (PubMed ID: 29535160)
1. Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.
Maroui MA; Maarifi G; McManus FP; Lamoliatte F; Thibault P; Chelbi-Alix MK
Mol Cell Proteomics; 2018 Jun; 17(6):1196-1208. PubMed ID: 29535160
[TBL] [Abstract][Full Text] [Related]
2. TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption.
El-Asmi F; El-Mchichi B; Maroui MA; Dianoux L; Chelbi-Alix MK
Cytokine; 2019 Aug; 120():264-272. PubMed ID: 31153006
[TBL] [Abstract][Full Text] [Related]
3. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
4. SUMOylation regulates the number and size of promyelocytic leukemia-nuclear bodies (PML-NBs) and arsenic perturbs SUMO dynamics on PML by insolubilizing PML in THP-1 cells.
Hirano S; Udagawa O
Arch Toxicol; 2022 Feb; 96(2):545-558. PubMed ID: 35001170
[TBL] [Abstract][Full Text] [Related]
5. Stability of Smyd1 in endothelial cells is controlled by PML-dependent SUMOylation upon cytokine stimulation.
Becker S; Steinemann G; Karle W; Roos K; Liem CH; Muralikumar S; Volkamer A; Munz B; Zakrzewicz A; Berkholz J
Biochem J; 2021 Jan; 478(1):217-234. PubMed ID: 33241844
[TBL] [Abstract][Full Text] [Related]
6. The ND10 Component Promyelocytic Leukemia Protein Acts as an E3 Ligase for SUMOylation of the Major Immediate Early Protein IE1 of Human Cytomegalovirus.
Reuter N; Schilling EM; Scherer M; Müller R; Stamminger T
J Virol; 2017 May; 91(10):. PubMed ID: 28250117
[TBL] [Abstract][Full Text] [Related]
7. Implication of PMLIV in both intrinsic and innate immunity.
El Asmi F; Maroui MA; Dutrieux J; Blondel D; Nisole S; Chelbi-Alix MK
PLoS Pathog; 2014 Feb; 10(2):e1003975. PubMed ID: 24586174
[TBL] [Abstract][Full Text] [Related]
8. NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.
Conde JN; Schutt WR; Mladinich M; Sohn SY; Hearing P; Mackow ER
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699085
[TBL] [Abstract][Full Text] [Related]
9. Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
Liu Y; Zhao D; Qiu F; Zhang LL; Liu SK; Li YY; Liu MT; Wu D; Wang JX; Ding XQ; Liu YX; Dong CJ; Shao XQ; Yang BF; Chu WF
Mol Ther; 2017 Mar; 25(3):666-678. PubMed ID: 28143738
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.
Maroui MA; Pampin M; Chelbi-Alix MK
J Virol; 2011 Dec; 85(24):13164-73. PubMed ID: 21994459
[TBL] [Abstract][Full Text] [Related]
11. Interferon, restriction factors and SUMO pathways.
El-Asmi F; McManus FP; Thibault P; Chelbi-Alix MK
Cytokine Growth Factor Rev; 2020 Oct; 55():37-47. PubMed ID: 32591223
[TBL] [Abstract][Full Text] [Related]
12. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
[TBL] [Abstract][Full Text] [Related]
13. Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.
McManus FP; Bourdeau V; Acevedo M; Lopes-Paciencia S; Mignacca L; Lamoliatte F; Rojas Pino JW; Ferbeyre G; Thibault P
Sci Rep; 2018 May; 8(1):7754. PubMed ID: 29773808
[TBL] [Abstract][Full Text] [Related]
14. Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs.
Dai J; Hu Y; Niu Q; Song G; Wang H; Li S
Life Sci; 2020 Jun; 251():117607. PubMed ID: 32240679
[TBL] [Abstract][Full Text] [Related]
15. Small Ubiquitin-like Modifier Alters IFN Response.
Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
[TBL] [Abstract][Full Text] [Related]
16. Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells.
Hirano S; Udagawa O; Kobayashi Y; Kato A
Toxicol Appl Pharmacol; 2018 Dec; 360():150-159. PubMed ID: 30292834
[TBL] [Abstract][Full Text] [Related]
17. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
18. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
[TBL] [Abstract][Full Text] [Related]
19. CACUL1/CAC1 attenuates p53 activity through PML post-translational modification.
Fukuda T; Kigoshi-Tansho Y; Naganuma T; Kazaana A; Okajima T; Tsuruta F; Chiba T
Biochem Biophys Res Commun; 2017 Jan; 482(4):863-869. PubMed ID: 27889610
[TBL] [Abstract][Full Text] [Related]
20. RING tetramerization is required for nuclear body biogenesis and PML sumoylation.
Wang P; Benhenda S; Wu H; Lallemand-Breitenbach V; Zhen T; Jollivet F; Peres L; Li Y; Chen SJ; Chen Z; de Thé H; Meng G
Nat Commun; 2018 Mar; 9(1):1277. PubMed ID: 29599493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
